Showing 1,268 results

Filters Content type: News, Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

Pharmaceutical industry

GSK and Gilead go head to head as HIV drugs enter new phase

Editor's pick
Reuters
2 November 2017
Confidentiality, consent & medical ethics

DC biohackers and blockchainers take on HIV

Editor's pick
Technical.ly DC
1 November 2017
New & experimental HIV treatments

Symtuza as effective as multi-pill combination in previously untreated people with HIV

News
28 October 2017
People with limited treatment options

Fostemsavir controls viral load in half of people with highly drug-resistant HIV

News
28 October 2017
The search for a cure

ABX464 reduces HIV reservoir but doesn’t delay viral rebound

News
26 October 2017
HIV treatment

Symtuza protease inhibitor regimen maintains viral suppression for a year

News
13 October 2017
Antibody-based treatment

Long-acting monoclonal antibody effective against multidrug-resistant HIV

News
12 October 2017
Resistance

Antibody-Based HIV Tx Proves Durable

Editor's pick
MedPage Today
10 October 2017
New & experimental HIV treatments

Bictegravir-Containing Regimen Found to Be Non-Inferior to Boosted Protease Inhibitor-based Regimens in Virologically Suppressed Adult Patients with HIV

Editor's pick
Gilead press release
4 October 2017
Access to healthcare

The Medicines Patent Pool and Gilead Sciences Sign Licence for Bictegravir

Editor's pick
Medicines Patent Pool
4 October 2017
New & experimental HIV treatments

Promising HIV Treatments in Late-Stage Clinical Development

Editor's pick
P&T Community
2 October 2017
Access to healthcare

Single-pill HIV treatment to save SA R11bn – health ministry

Editor's pick
News24
25 September 2017
Access to healthcare

New high-quality antiretroviral therapy to be launched in South Africa, Kenya and over 90 low-and middle-income countries at reduced price

Editor's pick
UNAIDS
22 September 2017
New & experimental HIV treatments

Immune 'Cocktails' Likely Needed in HIV

Editor's pick
MedPage Today HIV/AIDS
21 September 2017
New & experimental HIV treatments

Maraviroc matches boosted protease inhibitor treatment over 96 weeks

News
11 September 2017
New & experimental HIV treatments

Boosted darunavir plus lamivudine matches three-drug regimen

News
8 August 2017
The search for a cure

VRC01 antibody can delay but not prevent viral rebound after interruption of early treatment

News
2 August 2017
New & experimental HIV treatments

Long-acting NRTI shows promise for HIV treatment and PrEP

News
2 August 2017
New & experimental HIV treatments

First protease inhibitor combination pill maintains viral suppression

News
1 August 2017
New & experimental HIV treatments

Doravirine combination pill looks good for initial HIV treatment

News
27 July 2017
New & experimental HIV treatments

New integrase inhibitor bictegravir works well for first-line HIV treatment

News
25 July 2017
New & experimental HIV treatments

Long-acting cabotegravir + rilpivirine injection shows good results at 96 weeks

News
24 July 2017
New & experimental HIV treatments

Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV

Editor's pick
Business Wire
21 July 2017
New & experimental HIV treatments

The 2017 Pipeline Report

Editor's pick
Treatment Action Group
19 July 2017